29 research outputs found

    Demography of the George River Caribou Herd: Evidence of Population Regulation by Forage Exploitation and Range Expansion

    Get PDF
    The George River caribou herd in northern Quebec/Labrador increased from about 5000 animals in 1954 to 472,200 (or 1.1 caribou/km) prior to the 1984 calving season. The range used by the herd expanded from 160,000 to 442,000 sq km for the period 1971-84. The exponential rate of increase (r) was estimated at 0.11 in the 1970s. Calf:female ratio in autumn was relatively constant (x=0.52) from 1973 to 1983, but decreased to about 0.39 in 1984-86. The harvest rate was relatively low in the 1970s (about 3%/y), but seemingly increased in the mid-1980s to 5-7% as a result of more liberal regulations and a greater impetus to exploit caribou for subsistence. The cumulative impact of lower calf recruitment and more intensive hunting may have appreciably depressed the growth rate of the herd in 1984-86. A greater year-round competition for food resources and a greater energy expenditure associated with range expansion are presented as probable regulatory factors for the George River herd. It is argued that the nature of caribou-habitat interactions in continental regions generate long-term fluctuations in caribou numbers if human exploitation remains low. At present, wolf predation does not appear to be an important mortality factor capable of regulating the George River herd.Key words: caribou, population regulation, food limitation, northem Quebec, Labrador, wolf predationMots clés: caribou, régulation de la population, limitation de la nourriture, nord du Québec, Labrador, prédation des loup

    CAR-associated vesicular transport of an adenovirus in motor neuron axons.

    Get PDF
    Axonal transport is responsible for the movement of signals and cargo between nerve termini and cell bodies. Pathogens also exploit this pathway to enter and exit the central nervous system. In this study, we characterised the binding, endocytosis and axonal transport of an adenovirus (CAV-2) that preferentially infects neurons. Using biochemical, cell biology, genetic, ultrastructural and live-cell imaging approaches, we show that interaction with the neuronal membrane correlates with coxsackievirus and adenovirus receptor (CAR) surface expression, followed by endocytosis involving clathrin. In axons, long-range CAV-2 motility was bidirectional with a bias for retrograde transport in nonacidic Rab7-positive organelles. Unexpectedly, we found that CAR was associated with CAV-2 vesicles that also transported cargo as functionally distinct as tetanus toxin, neurotrophins, and their receptors. These results suggest that a single axonal transport carrier is capable of transporting functionally distinct cargoes that target different membrane compartments in the soma. We propose that CAV-2 transport is dictated by an innate trafficking of CAR, suggesting an unsuspected function for this adhesion protein during neuronal homeostasis

    2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project

    Get PDF
    We conducted a multicentre test-negative caseù\u80\u93control study in 27 hospitals of 11 European countries to measure 2015/16 influenza vaccine effectiveness (IVE) against hospitalised influenza A(H1N1)pdm09 and B among people aged ù\u89„ 65 years. Patients swabbed within 7 days after onset of symptoms compatible with severe acute respiratory infection were included. Information on demographics, vaccination and underlying conditions was collected. Using logistic regression, we measured IVE adjusted for potential confounders. We included 355 influenza A(H1N1)pdm09 cases, 110 influenza B cases, and 1,274 controls. Adjusted IVE against influenza A(H1N1)pdm09 was 42% (95% confidence interval (CI): 22 to 57). It was 59% (95% CI: 23 to 78), 48% (95% CI: 5 to 71), 43% (95% CI: 8 to 65) and 39% (95% CI: 7 to 60) in patients with diabetes mellitus, cancer, lung and heart disease, respectively. Adjusted IVE against influenza B was 52% (95% CI: 24 to 70). It was 62% (95% CI: 5 to 85), 60% (95% CI: 18 to 80) and 36% (95% CI: -23 to 67) in patients with diabetes mellitus, lung and heart disease, respectively. 2015/16 IVE estimates against hospitalised influenza in elderly people was moderate against influenza A(H1N1)pdm09 and B, including among those with diabetes mellitus, cancer, lung or heart diseases
    corecore